Related references
Note: Only part of the references are listed.Examination of HFE associations with childhood leukemia risk and extension to other iron regulatory genes
Amy E. Kennedy et al.
LEUKEMIA RESEARCH (2014)
Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes
[Anonymous]
JOURNAL OF CLINICAL PATHOLOGY (2013)
Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox
Shohei Kikuchi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Molecular Diagnostic and Pathogenesis of Hereditary Hemochromatosis
Paulo C. J. L. Santos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion-Dependent Patients With Myelodysplastic Syndrome
Alan F. List et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Iron overload in MDS-pathophysiology, diagnosis, and complications
Norbert Gattermann et al.
ANNALS OF HEMATOLOGY (2011)
Comparison of oxidative stress and the frequency of polymorphisms in the HFE gene between hemoglobin S trait blood donors and sickle cell disease patients
L. M. S. Viana-Baracioli et al.
GENETICS AND MOLECULAR RESEARCH (2011)
Oxidative Stress Levels in Myelodysplastic Syndrome Patients: their Relationship to Serum Ferritin and Haemoglobin Values
K. Saigo et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Antonello Pietrangelo
GASTROENTEROLOGY (2010)
Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes
Hussam Ghoti et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Iron deficiency and frequency of HFE C282Y gene mutation in Brazilian blood donors
C. T. Terada et al.
TRANSFUSION MEDICINE (2009)
Body iron metabolism and pathophysiology of iron overload
Yutaka Kohgo et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts
Zachary P. Nearman et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome
Hussam Ghoti et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Reactive oxygen species, DNA damage, and error-prone repair: A model for genomic instability with progression in myeloid leukemia?
Feyruz V. Rassool et al.
CANCER RESEARCH (2007)
The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndrome
Judit Varkonyi et al.
ANNALS OF HEMATOLOGY (2006)
Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort
Rita J. Guerreiro et al.
BMC NEUROLOGY (2006)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
L Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Oxidative stress and the myelodysplastic syndromes
MJ Farquhar et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: The Budapest study on 50 patients
J Varkonyi et al.
ACTA HAEMATOLOGICA (2003)
The World Health Organization (WHO) classification of the myeloid neoplasms
JW Vardiman et al.
BLOOD (2002)
Molecular aspects of iron absorption and HFE expression
S Parkkila et al.
GASTROENTEROLOGY (2001)
Share Paper
